A self-delivery membrane system for enhanced anti-tumor therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Cell membrane targeting therapy offers high anti-tumor efficacy by bypassing cellular barriers.
• Developing effective drug delivery systems for targeted cancer treatment remains a critical challenge.

Purpose of the Study:

• To construct a self-delivery membrane system (M-Cp) for precise cell membrane targeting therapy.
• To evaluate the in vivo targeting ability, immune response, and anti-tumor efficacy of the M-Cp system.

Main Methods:

• Conjugating therapeutic agents to chimeric peptides (Cp) and anchoring them in cracked cancer cell membranes (CCCM) to form M-Cp.
• Comparing the targeting retention time of M-Cp and Cp on cancer cell membranes.
• Investigating the role of specific membrane proteins in CCCM targeting.
• Assessing the tumor-specific immune response and anti-tumor effects of M-Cp.

Main Results:

• M-Cp demonstrated significantly longer retention time on cancer cell membranes compared to Cp.
• Superior targeting was attributed to specific proteins like focal adhesion proteins and integrins on CCCM.
• M-Cp enhanced tumor-specific immune response, leading to improved anti-tumor effects when combined with therapeutic agents.
• The M-Cp system showed potential as a versatile template for cell membrane targeting therapy.

Conclusions:

• The self-delivery M-Cp system enables precise and sustained cell membrane targeting therapy.
• This approach enhances anti-tumor efficacy through improved targeting and immune response modulation.
• The M-Cp strategy offers a flexible platform for developing advanced cancer therapies.